Blood sample.
Credit: © praisaeng / Fotolia
Cancer scientists led by principal investigator Dr. Daniel De Carvalho at Princess Margaret Cancer Centre have combined “liquid biopsy,” epigenetic alterations and machine learning to develop a blood test to detect and classify cancer at its earliest stages. The findings describe not only a way to detect cancer, but hold promise of being able to find it earlier when it is more easily treated and long before symptoms ever appear, says Dr. De Carvalho, Senior Scientist at the cancer centre, University Health Network.
“We are very excited at this stage,” says Dr. De Carvalho. “A major problem in cancer is how to detect it early...
Read More
Recent Comments